SNTI vs SRZN

Senti Biosciences Holdings, Inc vs Surrozen, Inc. — Valuation Comparison 2026

SNTI

Biological Products, (No Diagnostic Substances)
Senti Biosciences Holdings, Inc
Quality
4.1
out of 10
Value Trap
39
LOW
Price
$0.95
Last close
Models
9/13
Active
VS

SRZN

Biological Products, (No Diagnostic Substances)
Surrozen, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$26.21
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType SNTI Fair ValueSNTI Upside SRZN Fair ValueSRZN Upside
Bayesian DCF Intrinsic $0.52 -48.4% $11.96 -54.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.06 -93.6% $0.88 -97.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for SNTI vs SRZN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SNTI vs SRZN — Which Stock Is More Undervalued?

SRZN scores higher with a 4.1/10 quality rating vs SNTI's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Senti Biosciences Holdings, Inc (SNTI) and Surrozen, Inc. (SRZN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SNTI currently trades at $0.95 with a QOC of 4.1/10, while SRZN trades at $26.21 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).